As acetyltransferase p300 plays a key role in high glucose-induced oxidative stress through suppression of antioxidant genes, pharmacological inhibition of acetyltransferase p300 activity may be an ideal approach to reduce diabetes-induced endothelial senescence and associated aging related cardiovascular pathologies in diabetic patients. The gene discussed is EP300; the disease is diabetes mellitus.